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SUMMARY – Obesity is a low-grade chronic infl ammatory state, in which a cytokine chemerin 
with its immunometabolic modulation has an important role. We aimed to study in a healthy popula-
tion relationships between serum chemerin levels, lifestyle choices and magnetic resonance imaging 
(MRI) assessed volumes of abdominal visceral (VAT) and subcutaneous (SAT) adipose tissues, which 
have diff erent cytokine expression profi les. Overall, 73 healthy participants undertook lifestyle ques-
tionnaire and underwent anthropometric measurements along with MRI scanning of abdominal SAT 
and VAT. Furthermore, complete blood count was determined along with chemerin and fi brinogen 
serum levels. Regression model for prediction of chemerin serum levels was built after controlling for 
sex, age and anthropometric measures.  Median serum chemerin was 141 (125-195) ng/mL. Serum 
chemerin had a moderate positive correlation with SAT and VAT volumes. Th e two most important 
predictors of chemerin levels were MRI detected SAT and thigh circumference. Independently, 
chemerin levels were associated with smoking, preference of salty food, and favoring fl avor/simplicity 
of preparation over nutritional value of the food. Serum chemerin seems to be more strongly corre-
lated with the volume of abdominal SAT than VAT, with certain lifestyle choices infl uencing chemer-
in levels independently of abdominal fat.
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Introduction
Obesity is recognized as a low-grade chronic in-
fl ammatory state. It is associated with increased mor-
tality and numerous morbidities including metabolic 
syndrome, diabetes mellitus type 2 and coronary artery 
disease1,2. Adipose tissue (AT) secretes immunometa-
bolic modulators called adipokines. Excessive AT has 
altered secretion profi le, where several adipokines (or 
their lack) contribute to the pathophysiology of these 
comorbid diseases3,4. One such molecule secreted by 
AT is chemerin, also known as retinoic acid receptor 
responder protein 2 (RARRES2)5. As a potent sig-
naling molecule, chemerin has been described as adi-
pokine, cytokine, paracrine/autocrine hormone, tu-
T. Salha et al. Chemerin, adipose tissue and lifestyle
664 Acta Clin Croat, Vol. 56, No. 4, 2017
mor-suppressor, anti-microbiological and angiogenic 
agent5.
Th e primary production sites of chemerin in the 
body are the liver and adipose tissue; it is also expressed 
at lower concentrations in the pancreas and adrenal 
gland6. It is known that chemerin is a ligand of three 
receptors: chemokine-like receptor 1 (CMLKR1), 
G-protein coupled receptor 1 (GPR1) and chemokine 
(C-C motif ) receptor-like 2 (CCRL2). Th e most 
widely studied has been signaling through CMLKR1, 
while the roles of GPR1 and CCRL2 mostly remain 
to be elucidated, with the latter probably lacking intra-
cellular signaling cascade7,8. CMLKR1 is expressed in 
various tissues, with highest expression in several in-
fl ammatory (spleen, placenta and lymph nodes) and 
non-infl ammatory related sites (vena cava, lungs and 
urinary bladder)9,10. CMLKR1 expression profi le is 
notably high in dendritic cells and macrophages7,8.
Chemerin regulates lipid metabolism and mesen-
chymal stem cell adipogenesis through autocrine/para-
crine mechanisms11,12. Lack of chemerin or CMLKR1 
expression in vitro abrogates adipogenesis, and modi-
fi es the expression of genes important in glucose and 
lipid metabolism, including glucose transporter type 4 
(GLUT4), leptin and adiponectin13. Higher chemerin 
expression in AT is associated with metabolic syn-
drome and its metabolic disturbances14. Furthermore, 
chemerin mediates infi ltration of macrophages in AT, 
and these are considered to be crucial cells in infl am-
matory activation of adipocytes in obesity13,15.
Morbidity/mortality risk is higher for abdominal 
than for overall obesity. Overall abdominal fat is a sum 
of subcutaneous (SAT) and visceral (VAT) adipose 
tissue, the latter consisting mainly of mesenteric, 
omental and retroperitoneal fat tissue16. Ibrahim et al.17 
have shown that, in comparison to SAT, VAT contains 
higher amounts of infl ammatory immune cells and 
greater number of large adipocytes, and that its pre-
adipocytes have a weaker capacity to diff erentiate. Fur-
thermore, VAT adipocytes are more insulin resistant, 
more metabolically active, and secrete a larger number 
of cytokines. Correlation of metabolic risk factors (in-
creased body mass index (BMI), triacylglyceride, glu-
cose, blood pressure, C-reactive protein (CRP) and 
decreased high density lipoprotein) with SAT and 
VAT has already been established, with the latter 
showing stronger correlation18. Furthermore, VAT cor-
relates to a greater extent with metabolic risk factors in 
women18. Alfadda et al.19 in a study of overweight sub-
jects (BMI >25 kg/m2) did not establish diff erence in 
serum chemerin level between metabolically healthy 
(had fewer than two above mentioned metabolic risk 
factors) and metabolically unhealthy obese.
Chemerin mRNA expression in VAT and SAT in 
lean individuals was signifi cantly lower than in obese 
patients, but did not diff er in the expression levels be-
tween VAT and SAT20. Th is suggested that correlation 
between chemerin and BMI was only due to the in-
crease in fat mass. On the contrary, mRNA chemerin 
expression in patients with type 2 diabetes mellitus 
and obese subjects was higher in VAT than in SAT9. A 
recent large study by Zylla et al.21 established the as-
sociation between AT volumes, infl ammation markers 
and chemerin levels.
As distribution of AT is of a well-known impor-
tance (i.e. for cardiovascular disease), there are numer-
ous attempts to directly, through imaging techniques, 
or indirectly (i.e. using diff erent anthropometric mea-
sures) assess the quantity of AT in diff erent depots. 
Assessment of SAT and VAT by magnetic resonance 
imaging (MRI) or computed tomography (CT) and 
post mortem assessment correlated well22. Anthropo-
metric measures showed positive correlations with post 
mortem AT volumes only in certain study groups (i.e. 
quantity of VAT measured by MRI (20 cm above and 
10 cm below the L4 and L5 intervertebral disk) in 
obese subjects (BMI 30.0 to 39.9 kg/m2), and positive 
correlation with waist circumference (WC) and waist-
hip ratio (WHR) only in females)23.
Only a few studies have investigated the relation-
ship between AT volumes and blood chemerin21,24. 
Metabolic disturbances do not appear only among 
obese individuals (i.e. normal-weight obesity syn-
drome), and the knowledge about the underlying mo-
lecular and environmental mechanisms is rather scarce. 
Due to the association of chemerin with metabolic 
disturbances13,15, it would be of interest to get an in-
sight into the eff ect of environmental factors (i.e. diet, 
physical activity) on chemerin level and body fat dis-
tribution in a healthy, non-obese population. More-
over, it would be valuable to study long-term eff ects of 
these ‘lifestyle’ factors. In order to answer some of 
these questions, we studied relationships between 
chemerin, dietary/lifestyle habits and volumes of ab-
dominal VAT and SAT in a cross-sectional manner in 
a healthy, non-obese population.
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 Th e goals of this study were to establish (1) rela-
tionship between chemerin serum levels and adipose 
tissue volumes of abdominal region; (2) to compare 
anthropometric measures to MRI acquired parameters 
in chemerin serum level prediction; and (3) to explore 
how certain lifestyle and dietary habits infl uence 
chemerin serum levels in a healthy, adult population.
Patients and Methods
Physical examination, laboratory blood tests 
and health/habits/lifestyle questionnaire
Th e study was approved by the local ethics com-
mittee and all persons gave their informed consent 
prior to their inclusion in the study. Th e sample con-
sisted of 73 healthy Caucasians (34 females), recruited 
volunteers and students from the School of Medicine, 
University of Osijek, Croatia. Medical history was 
taken in each subject and only those without prior 
medical conditions were included in the study. Th e 
median age of the participants was 24 (21-33) years. 
Physical examination included anthropometry 
(weight, height, WC at the level of umbilicus, hip cir-
cumference at the level of greater trochanters, thigh 
circumference at the middle third of the thigh, triceps 
skinfold thickness at the middle third of the upper 
arm, and subscapular skinfold thickness (SST)), vital 
signs check (blood pressure), and laboratory blood 
tests (complete blood count, fi brinogen, chemerin). All 
participants undertook a questionnaire assessing life-
style and eating habits. Th e mean arterial pressure 
(MAP) was calculated as the sum of diastolic blood 
pressure and one-third of systolic blood pressure. VAT/
SAT is the ratio of abdominal VAT volume to SAT 
volume. BMI was defi ned as the ratio of weight in ki-
lograms to squared height in meters.
MRI
Th e SAT and VAT were measured with MRI (Sie-
mens Magnet Avanto 1.5T MRI System, DMS 
Health Technologies, ND, USA), using standardized 
T1 ‘fast spin echo’ sequence for measuring AT. Th e ab-
dominal region of interest was from the upper liver 
edge to the pubic symphysis. AT volume calculation 
was based on approximately 20 slices per participant. 
Th e program used for analyzing MRI images was 
open-source ImageJ. Adipose tissue was distinguished 
using intensity threshold macro-program, which made 
pictures binary, leaving only those intensities above 
curtain cut off  value. On each slab, surface area of SAT 
and VAT was manually measured using the region of 
interest principal. Th e volume of AT was calculated ac-
cording to the MRI parameters, multiplying surface 
area of adipose tissue on each slab with slab thickness 
and corresponding distance between the measured 
slab and subsequent one. MRI acquisition and post 
processing was done by a radiologist with more than 
10 years of experience in MRI body imaging.
Chemerin ELISA
Chemerin was quantifi ed using human chemerin 
enzyme-linked immunosorbent assay (ELISA) kit 
(Enzo Life Sciences, Farmingdale, NY, USA). Blood 
sampling was performed early in the morning on an 
empty stomach, after less than 12-hour fasting.
Statistics
Values are presented as median [Q1-Q3] or mean 
(±SD) depending on the distribution. Distribution of 
variables was tested using Shapiro-Wilk test. Normal-
ly distributed variables were compared using paramet-
ric Student’s t-test and one-way ANOVA. Variables 
that were not normally distributed were compared us-
ing nonparametric Mann-Whitney and Kruskal-Wal-
lis tests. In order to perform relationship analyses, 
Pearson correlation and multiple regression analysis 
with forward stepwise method of fi tting were used. 
Prior to regression model building, independent pre-
dictor variables were screened for multicolinearity and 
singularity. A two-sided p<0.05 was considered sig-
nifi cant. IBM SPSS Statistica v. 15.0 was used on sta-
tistical analyses.
Results
Th e overall descriptive results of the study partici-
pants are shown in Table 1. Chemerin blood levels 
correlated with VAT and SAT volume (r=0.419, 
p<0.001; and r=0.482, p<0.001, respectively) (Fig. 1B 
and 1C), subscapular skinfold thickness and WC 
(r=0.364, p=0.009, and r=0.289, p=0.036, respectively). 
Other classical anthropometric measures did not cor-
relate (data not shown). Among analyzed blood pa-
rameters, chemerin blood levels showed a moderately 
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strong positive correlation with fi brinogen levels 
(r=0.403, p=0.004), whereas mean corpuscular volume 
(MCV) showed a weak negative correlation (r=-0.284, 
p=0.036), and other parameters did not correlate with 
chemerin. Fibrinogen blood levels had a weak positive 
correlation with SAT volume (p=0.047), but not with 
VAT volume (p=0.074) (Fig. 1E and 1F).
To predict chemerin serum levels, a stepwise re-
gression model was employed with MRI measured 
adipose tissue volumes, anthropometric measures, 
complete blood count and fi brinogen levels as inde-
pendent predictors controlled for age and sex. Th e fi nal 
model explained 40.6% of variance in chemerin serum 
levels and included the following variables as the most 
important predictors (from most to least important): 
thigh circumference, SAT, fi brinogen, hip circumfer-
ence, and red blood cells (RBC), while other indepen-
dent variables were excluded from the fi nal model 
(Table 2).
Lifestyle and dietary habits
Participants that preferred salty food had higher 
chemerin (163±46 vs. 136±40 ng/mL, p=0.045) and 
fi brinogen (3.15±0.66 vs. 2.85±0.40 mg/d, p=0.05) 
levels. Th e subjects considering nutritional facts to be 
the most important factor when buying food had  lower 
chemerin than those who found fl avor (p=0.029) and 
simplicity of preparation (p=0.005) to be most impor-
tant. Study participants that smoked (37.3%) had 
higher chemerin serum levels compared to those who 
Table 1. Descriptive results of study participants (N=73) for all participants with additional stratifi cation according to 
gender
Overall Female Male
Anthropometry Age (yrs) 24 (21-33) 21 (21-29) 30 (21-38)
Height (cm) 176 (167-183) 168 (163-173) 182 (176-187)
Weight (kg) 76 (61-89) 63 (56-68) 88 (70-98)
Body mass index (kg/m2) 24.0 (21.4-27.0) 21.7 (20.5-23.3) 26.0 (24.9-29.1)
Waist circumference (cm) 84 (72-94) 72 (67-79) 94 (86-106)
Hip circumference (cm) 95 (89-102) 90 (86-93) 100 (95-106)
Th igh circumference (cm) 52 (49-56) 49 (46-52) 55 (52-58)
Triceps skinfold thickness (mm) 16 (14-20) 17 (14-20) 16 (12-22)
Subscapular skinfold thickness (mm) 16 (12-24) 13 (10-16) 23 (14-29)
Mean arterial pressure (mm Hg) 92 (83-100) 87 (80-97) 94 (88-105)
MRI SAT (L) 3.37 (2.61-4.47) 3.32 (2.37-4.14) 3.61 (2.75-5.71)
VAT (L) 1.25 (0.74-2.32) 0.83 (0.58-1.12) 2.20 (1.27-3.12)
VAT/SAT 0.37 (0.24-0.59) 0.24 (0.19-0.32) 0.57 (0.40-0.65)
ELISA Chemerin (ng/mL) 141 (125-195) 137 (124-192) 154 (131-195)
Blood work Red blood cells (x1012/L) 4.7(4.3-5.2) 4.3 (4.1-4.6) 5.1 (4.7-5.2)
Hemoglobin (g/L) 138 (129-152) 130 (123-135) 151 (144-158)
Hematocrit (%) 41 (39-45) 39 (37-40) 44 (42-46)
MCV (fL) 88 (86-91) 89 (87-93) 86 (84-89)
MCH (pg) 30 (29-31) 30 (28-30) 30 (29-31)
MCHC (g/L) 333 (325-345) 326 (323-338) 342 (331-350)
Platelets (x109/L) 233 (208-276) 255 (217-287) 220 (193-259)
Fibrinogen (g/L) 3 (2.5-3.4) 3 (2.5-3.4) 2.9 (2.5-3.6)
White blood cells (x109/L) 6.4 (5.5-7.3) 6.5 (5.8-7.3) 6.2 (5.4-7.3)
Results are shown as median (Q1-Q3); MRI = magnetic resonance imaging; ELISA = enzyme-linked immunosorbent assay; SAT = sub-
cutaneous adipose tissue; VAT = visceral adipose tissue; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC 
= mean corpuscular hemoglobin concentration.
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Fig. 1. Correlations of blood chemerin levels with abdominal adipose tissue volumes, anthropometric measures 
and blood parameters.
BMI (A), as well as other classical anthropometric measures, except for waist circumference and subscapular skinfold thickness, did not 
correlate with serum chemerin. MRI measured volumes of abdominal visceral (B) and subcutaneous (C) adipose tissue had a moderate 
positive correlation with serum chemerin. Chemerin and blood fi brinogen levels (D) showed moderately strong positive correlation. 
 Fibrinogen levels did not correlate with abdominal visceral adipose tissue volume (E), but it showed a weak positive correlation with 
 abdominal subcutaneous adipose tissue volume (F).
BMI = body mass index; VAT = visceral adipose tissue; SAT = subcutaneous adipose tissue
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did not smoke (172±40 vs. 144±40 ng/mL, p=0.02). 
Participants who consumed alcohol on a regular basis 
(87%; at least 3 times or more a month) had similar 
chemerin serum levels as their counterparts who did 
not consume alcohol (p=0.424). Additional stratifi ca-
tion of participants by alcohol consumption rate did 
not show any diff erences in chemerin serum levels. 
Furthermore, study participants that exhibited binge 
drinking behavior (31.3%) did not diff er in chemerin 
serum levels (149±42 vs. 175±55 ng/mL, p=0.123).
Furthermore, those who considered nutritional 
facts most important had less VAT (p=0.048) and SAT 
(p=0.040) than those who considered price as the main 
criterion whether to purchase the product. Participants 
who had breakfast more often (6-7 times a week) had 
less SAT compared to those who had breakfast less 
often (3-5 times a week) or not at all (p=0.018 and 
p=0.028, respectively). Th ere was also a diff erence be-
tween the groups with diff erent breakfast habits in hip 
circumference and thigh circumference (p=0.058 and 
p=0.032, respectively). Also, participants who fre-
quently ate small meals (snacks) several times a week 
or every day, had smaller WC (p=0.037 and p=0.021, 
respectively) and thigh circumference (p=0.009 and 
p=0.053, respectively) than those who snacked seldom 
or never.
Participants who preferred high-fat dairy products 
had a higher VAT/SAT ratio than those taking medi-
um- or low-fat dairy products (p=0.040 and p=0.020, 
respectively). People who were choosing food for 
themselves had lower thigh circumference than those 
whose food was chosen by their partner or family 
(p=0.036 and p=0.013, respectively). Participants con-
suming olive oil regularly (compared to those using it 
occasionally or never) had greater triceps skinfold 
thickness (p=0.001 and p=0.004, respectively) and 
SST (p=0.019 and p=0.003, respectively). People con-
suming chocolate more than once a week had lower 
mean arterial pressure than people enjoying chocolate 
1-4 times per month or less than once a month 
(p=0.040 and p=0.004, respectively). 
Discussion
Chemerin is suggested as a biomarker of visceral 
adiposity and associated infl ammatory process21. A re-
cent study by Zylla et al. was the fi rst to use MRI to 
assess volumes of total abdominal AT and chemerin. 
In line with our results, they established that both SAT 
and VAT were positively, mutually independently, as-
sociated with chemerin21. Due to the suggested role of 
chemerin as a predictor and risk factor for the develop-
ment of metabolic syndrome and atherosclerotic pro-
cess21, it would be valuable to identify individuals at 
risk through low-cost measures such as classical an-
thropometric measures. Similar to our results, Zylla et 
al.21 clearly showed that chemerin increased steadily 
with increasing WC. Other inexpensive anthropomet-
ric measures such as triceps skinfold thickness and 
SST might also be of interest. Herein, we presented 
correlation of chemerin with SST that has not been 
established before. SST is a seldom used anthropo-
metric parameter and is usually considered as a mea-
sure of truncal SAT25. Interestingly, SST was found to 
be the only valuable classical anthropometric measure 
which distinguished between transient and persistent 
Table 2. Stepwise forward regression model for chemerin serum level prediction with MRI 
measured adipose tissue volumes, anthropometric measures, complete blood count and 
fi brinogen levels as independent predictors – fi nal model independent variables controlled 
for age and sex, which are the most important predictors of chemerin serum levels
Independent predictor Coeffi  cient p
95% Confi dence interval
Lower Upper
Th igh circumference (cm) -7.256 0.001 -11.241 -3.270
Subcutaneous adipose tissue (mL) 0.011 0.001 0.005 0.018
Fibrinogen (g/L) 31.284 0.002 12.556 50.012
Hip circumference (cm) 2.340 0.028 0.269 4.410
Red blood cells (x1012/L) 23.428 0.044 0.709 46.148
Intercept -159.536 0.248 -433.408 114.835
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impaired glucose tolerance26. Also, Savastano et al. 
showed that SST was the adiposity measure with the 
strongest negative association with blood level of insu-
lin-like growth factor-I binding protein 1, known to 
be altered inversely proportionally to the degree of vis-
ceral adiposity27,28. On the contrary, a study by Vasan et 
al. implied that abdominal skinfold rather than SST 
was associated with elevated blood glucose29. Never-
theless, it would be interesting to include SST in fu-
ture studies aimed to assess factor clustering in meta-
bolic and atherosclerotic phenotypes (i.e. disturbances 
in glucose, insulin and blood lipid regulation).
Not surprisingly, chemerin showed stronger corre-
lation with MRI-assessed volumes of SAT and VAT 
than with the traditional anthropometric measures. 
On the other hand, regression analysis showed that, 
besides SAT, a ‘classical’  thigh circumference (a mea-
sure of SAT) was the most important predictor of 
chemerin level. A potential explanation why VAT did 
not emerge as a predictor of chemerin level is a modest 
sample size and rigorous controlling in the forward 
stepwise regression model. Additionally, although 
chemerin was clearly associated with visceral obese 
phenotypes, expression of chemerin mRNA in SAT 
and VAT did not diff er in healthy, lean (BMI <25 kg/
m2) adults9. It is important to stress that absolute body 
volume of SAT is greater in both sexes30. With com-
mon single L4/L5 slice approach the results are skewed 
and miss much of the diversity of human body fat dis-
tribution. Although we assessed the majority of body 
VAT, unembraced SAT is also hormonally active tis-
sue, where classical anthropometric measures ensure 
an insight into its quantity in other body regions.
Solely reducing BMI after bariatric surgery showed 
reduction of chemerin in a follow-up study9. Alterna-
tively, after a 12-week exercise program, chemerin lev-
els decreased without change in BMI. Th e exercise did, 
however, increase insulin sensitivity and decreased in-
fl ammatory activity (as assessed by CRP)9. Several 
studies31-33 also showed that blood chemerin decreased 
after exercise and dietary interventions (calorie restric-
tion and education), but did not investigate separately 
the eff ects of dietary habits. An interesting study by 
Khoo et al. on obese men after similar daily negative 
energy balance for 24 weeks, either through exercise 
regimen or through diet-intervention, showed similar 
decrease in weight and WC, but greater reduction of 
fat mass, chemerin and CRP in the exercise group. 
Additionally, only exercising participants showed in-
creased levels of the ‘good’ adipokine, adiponectin34. 
We showed that higher chemerin levels were present 
in healthy subjects who preferred salty food and those 
who primarily were thinking of simplicity of prepara-
tion or taste while buying food, as opposed to subjects 
whose primary concern was nutritive value regardless 
of their BMI. Such association between chemerin and 
dietary habits has not been documented earlier and in-
creased sodium intake is associated with several mor-
bidities. Although all our subjects were healthy, these 
data fi t into the ‘healthy lifestyle picture’ of the popula-
tion with lower chemerin. It is alluring to hypothesize 
that long-term eff ects of diff erent adverse environ-
mental factors might be partially mediated through 
chemerin, i.e. through long-term, silent ‘infl ammation 
excess’.
Obesity is characterized by increased levels of 
chemerin and fi brinogen2,35. Our study confi rmed the 
association between chemerin and fi brinogen levels in 
a healthy population21,36. We still lack an explanation 
for the association, but we can conjecture that chronic 
infl ammation in hypertrophic AT might underlie in-
creases in the blood levels of both parameters. Never-
theless, as both fi brinogen and chemerin have been es-
tablished as independent factors associated with the 
development of atherosclerosis, even in healthy sub-
jects, the possible risk of developing cardiovascular 
diseases should be noted36,37.
Th e study by Chakaroun et al. off ered a valuable 
insight into chemerin production; mRNA expression 
in omental (VAT) and SAT was similar in both depots 
in lean and obese (but higher in obese), and higher in 
VAT than in SAT of diabetic subjects9. Th erefore, both 
AT depots are important producers of chemerin. Fur-
thermore, it should be kept in mind that AT is not a 
single-cell type tissue and diff erent expression profi les 
of cells within AT might explain discrepancies in the 
results from mRNA-based studies of VAT and SAT9,20.
It should not be forgotten that chemerin is not 
produced only in AT; the pancreas, liver and lungs are 
suggested to be greater sources14. Interestingly, in mice, 
chemerin was directly involved in local infl ammatory 
response following exposure to cigarette smoke38. In-
formation on environmental eff ects on chemerin levels 
is rather scant. Boyuk et al. report that chronic ob-
structive pulmonary disease patients with a history of 
smoking had higher chemerin than control (never-
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smokers) group39. Herenius et al. established ‘a trend 
towards higher levels of chemerin in current smokers 
than in non-smokers’ among patients with rheumatoid 
arthritis40. We showed that even in healthy population 
chemerin was higher among smokers. Th ese results fi t 
into the paradigm of unhealthy lifestyle choices lead-
ing to atherosclerosis and cardiovascular disease.
Data on the eff ects of alcohol intake on chemerin 
are limited. Chronic heavy drinking (>48 g/d) in-
creased chemerin, whereas a study on rats suggested 
that elevated chemerin mostly refl ected increased pro-
duction in hypertrophic VAT41. In line with this study, 
in our group of mostly non-drinkers and occasional 
alcohol consumers, we did not establish any such as-
sociation.
In conclusion, adipose tissue volumes of abdominal 
region moderately positively correlated with serum 
chemerin levels, while SAT volume, along with  thigh 
circumference (anthropometric marker of SAT ) was a 
more important predictor of serum chemerin levels 
than VAT after controlling for gender, age and BMI. 
Additionally, hip circumference was also shown to be 
an important predictor of serum chemerin levels. Fur-
thermore, our results imply that dietary habits and 
lifestyle choices such as smoking, salt preference, 
healthy and ‘slow’ food, may infl uence blood chemerin 
levels independently of AT volumes. Finally, this study 
points in the direction of abdominal SAT and its rela-
tive contribution compared to VAT, as one of the ma-
jor sources of chemerin, which might be a piece of 
puzzle underlying normal-weight obesity and meta-
bolic syndrome.
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Sažetak
RAZINA KEMERINA U KRVI JE POVEZANA S VOLUMENIMA TRBUŠNOG MASNOG TKIVA 
IZMJERENIMA POMOĆU MAGNETSKE REZONANCIJE I ČIMBENICIMA STILA ŽIVOTA
T. Salha, D. Andrijević, Z. Vrselja, V. Šerić, R. Radić i G. Curic
Pretilost je stanje obilježeno kroničnom upalom niskog intenziteta u kojoj citokin kemerin, imunometabolički modulator, 
ima važnu ulogu. Cilj studije je bio u zdrave populacije istražiti odnose između serumskih razina kemerina, životnih navika i 
magnetnom rezonancijom (MR) utvrđenih volumena abdominalnog visceralnog (VMT) i subkutanog (SMT) masnog tkiva 
za koje je pokazano da imaju drukčije citokinske ekspresijske profi le. U studiju su bila uključena 73 zdrava sudionika koji su 
odgovorili na upitnik o životnim navikama, potom su izmjerene njihove antropometrijske mjere te utvrđeni volumeni abdo-
minalne regije VMT i SMT pomoću MR. U svih ispitanika je napravljena kompletna krvna slika uz procjenu serumskih 
razina kemerina i fi brinogena. Učinjeni su regresijski modeli za procjenu serumskog kemerina uz kontrolu prema spolu, dobi 
i antropometrijskim mjerama. Serumska vrijednost kemerina iznosila je 141 (125-195) ng/mL. Serumski kemerin srednje 
jako je korelirao s volumenom SMT i VMT. Dva najvažnija prediktora serumskog kemerina bili su volumen SMT i opseg 
natkoljnice. Nezavisno od volumetrijskih mjerenja, pušenje, slana hrana i preferiranje okusa/jednostavne prehrane imali su 
utjecaja na serumski kemerin. Serumski kemerin jače je povezan s volumenom SMT nego VMT, dok nezavisno od volume-
na masnog tkiva određene životne navike utječu na razine serumskog kemerina.
Ključne riječi: Pretilost; Citokini – krv; Magnetska rezonancija, snimanje; Fibrinogen; Abdominalno salo; Adipokini; Intra-
abdominalno salo; Način života; Pušenje
